In murine tumour models, elevated VEGF-A levels increased PD-1 on CD8+ T cells via VEGFR2 and downstream NFAT-dependent pathways, and blockade of VEGF-A/VEGFR reversed this upregulation and alleviated T cell exhaustion [171]. Here, PDCD1 is linked to neoplasm.